PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Formaat:	Artikel
Taal:	Russian
Gepubliceerd in:	Remedium Group LLC 2017-11-01
Reeks:	Медицинский совет
Onderwerpen:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Online toegang:	https://www.med-sovet.pro/jour/article/view/2007

Gelijkaardige items

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
door: Annina S. Vischer, et al.
Gepubliceerd in: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
door: Chinonyerem O. Iheanacho, et al.
Gepubliceerd in: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
door: Piotr Skonieczny, et al.
Gepubliceerd in: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
door: Yang Zhao, et al.
Gepubliceerd in: (2018-01-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
door: Kuang-Ming Liao, et al.
Gepubliceerd in: (2023-11-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
door: Jordan Loader, et al.
Gepubliceerd in: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
door: Simon B. Gressens, et al.
Gepubliceerd in: (2021-02-01)

Angiotensins and rheumatoid arthritis
door: N. M. Savushkina, et al.
Gepubliceerd in: (2019-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
door: JungMin Choi, et al.
Gepubliceerd in: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
door: Leonard K. Wang, et al.
Gepubliceerd in: (2023-06-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
door: N. V. Drobotya, et al.
Gepubliceerd in: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
door: Yipeng Fang, et al.
Gepubliceerd in: (2024-08-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
door: Jilong XU, et al.
Gepubliceerd in: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
door: Anna V. Aksenova, et al.
Gepubliceerd in: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
door: S. V. Stolov
Gepubliceerd in: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
door: Konstantinos Tziomalos, et al.
Gepubliceerd in: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
door: T E Morozova
Gepubliceerd in: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
door: K. A. Ghyamdzhyan, et al.
Gepubliceerd in: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
door: Stine Andersen, et al.
Gepubliceerd in: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
door: S Ravitej, et al.
Gepubliceerd in: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
door: Hye-Jin Park, et al.
Gepubliceerd in: (2022-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
door: Ann Z. Bauer, et al.
Gepubliceerd in: (2021-01-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
door: Steven M. Smith, et al.
Gepubliceerd in: (2023-01-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
door: Joachim Beige
Gepubliceerd in: (2019-06-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
door: Maksimov M.L., et al.
Gepubliceerd in: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
door: M L Maksimov, et al.
Gepubliceerd in: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
door: Hany A Al-Hussaniy, et al.
Gepubliceerd in: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
door: Yohko Nagai, et al.
Gepubliceerd in: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
door: M L Maksimov
Gepubliceerd in: (2010-06-01)

The Evolving Role of Calcium Channel Blockers in Hypertension Management: Pharmacological and Clinical Considerations
door: Kamryn E. Jones, et al.
Gepubliceerd in: (2024-06-01)

Dataset for discovering new hypertension small molecules using machine learning-aided computational fragment-based design
door: Odifentse Mapula-e Lehasa, et al.
Gepubliceerd in: (2024-08-01)

The complete reversal effect following angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and beta-blockers after the primary diagnosis of dilated cardiomyopathy
door: Tao Liu, et al.
Gepubliceerd in: (2023-01-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
door: A. E. Bragina, et al.
Gepubliceerd in: (2005-12-01)

Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer
door: Marcin Zeman, et al.
Gepubliceerd in: (2022-07-01)

Impact of Renin‐Angiotensin System Inhibitors on Long‐Term Clinical Outcomes of Patients With Coronary Artery Spasm
door: Byoung Geol Choi, et al.
Gepubliceerd in: (2016-07-01)

Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system
door: S. G. Kanorskiy
Gepubliceerd in: (2021-04-01)

Calcium Channel Blocker Versus Renin–Angiotensin System Inhibitor in Risk of Kidney Cancer Among Patients With Hypertension: A Propensity Score‐Matched Cohort Study
door: Minji Jung, et al.
Gepubliceerd in: (2024-11-01)

Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
door: Gemma García-Lluch, et al.
Gepubliceerd in: (2023-03-01)

Corrigendum: Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
door: Kuang-Ming Liao, et al.
Gepubliceerd in: (2024-06-01)

From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift
door: O D Ostroumova, et al.
Gepubliceerd in: (2015-12-01)